Valuation check: HSDT's profit margin is -1427.17%, below the Technology sector average of 37.42%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Helius Medical Technologies (HSDT) currently reports a profit margin of -1427.17% as of March 2026. That compares with -3010.14% in the prior-year period — up 52.6% year over year. That is below the Technology sector average of 37.42%. Use the charts on this page to explore Helius Medical Technologies's profit margin history and peer comparisons.
Helius Medical Technologies's profit margin increased from -3010.14% to -1427.17% — a 52.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Helius Medical Technologies's profit margin of -1427.17% is lower than the Technology sector average of 37.42%. That is roughly 3913.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Helius Medical Technologies's current -1427.17% should be judged against Technology norms (sector average: 37.42%) and against HSDT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -1427.17%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 37.42%. From there, open related valuation or income-statement pages for Helius Medical Technologies, and consider following HSDT for alerts when major investors trade the stock.